- CKbeta8-1 alters expression of cyclin E in colony forming units-granulocyte macrophage (CFU-GM) lineage from human cord blood CD34 + cells
-
Noh EK, Ra JS, Lee SA, Kwon BS, Han IS
- KMID: 1116207
- Exp Mol Med.
- 2005 Dec;37(6):619-623.
A C6 beta-chemokine, CKbeta8-1, suppressed the colony formation of CD34 + cells of human cord blood (CB). Molecular mechanisms involved in CKbeta8-1-medicated suppression of colony formation of CD34 + cells... -
- CITED
-
- Close
- SHARE
-
- Close
- Direct and Indirect Effects of Androgens on Survival of Hematopoietic Progenitor Cells In Vitro
-
Kim SW, Hwang JH, Cheon JM, Park NS, Park SE, Park SJ, Yun HJ, Kim S, Jo DY
- KMID: 1778498
- J Korean Med Sci.
- 2005 Jun;20(3):409-416.
- doi: 10.3346/jkms.2005.20.3.409
Androgens remain a common treatment for certain type of anemia, based upon its myelostimulating effects; however, it has not been established whether androgens affect apoptosis of hematopoietic progenitor cells (HPCs).... -
- CITED
-
- Close
- SHARE
-
- Close
- Implications and limitations of cellular reprogramming for psychiatric drug development
-
Tobe BT, Brandel MG, Nye JS, Snyder EY
- KMID: 2154278
- Exp Mol Med.
- 2013 Nov;45(11):e59.
Human-induced pluripotent stem cells (hiPSCs) derived from somatic cells of patients have opened possibilities for in vitro modeling of the physiology of neural (and other) cells in psychiatric disease states.... -
- CITED
-
- Close
- SHARE
-
- Close
- Labeling Efficacy of Superparamagnetic Iron Oxide Nanoparticles to Human Neural Stem Cells: Comparison of Ferumoxides, Monocrystalline Iron Oxide, Cross-linked Iron Oxide (CLIO)-NH2 and tat-CLIO
-
Song M, Moon WK, Kim Y, Lim D, Song IC, Yoon BW
- KMID: 1734284
- Korean J Radiol.
- 2007 Oct;8(5):365-371.
- doi: 10.3348/kjr.2007.8.5.365
OBJECTIVE: We wanted to compare the human neural stem cell (hNSC) labeling efficacy of different superparamagnetic iron oxide nanoparticles (SPIONs), namely, ferumoxides, monocrystalline iron oxide (MION), cross-linked iron oxide (CLIO)-NH2... -
- CITED
-
- Close
- SHARE
-
- Close
